Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Lower-grade gliomas of histologic grades 2 and 3 follow heterogenous clinical outcomes, which necessitates risk stratification. This study aimed to evaluate whether diffusion-weighted and perfusion-weighted MRI radiomics allow overall survival (OS) prediction in patients with lower-grade gliomas and investigate its prognostic value. Materials and Methods: In this retrospective study, radiomic features were extracted from apparent diffusion coefficient, relative cerebral blood volume map, and Ktrans map in patients with pathologically confirmed lower-grade gliomas (January 2012–February 2019). The radiomics risk score (RRS) calculated from selected features constituted a radiomics model. Multivariable Cox regression analysis, including clinical features and RRS, was performed. The models’ integrated area under the receiver operating characteristic curves (iAUCs) were compared. The radiomics model combined with clinical features was presented as a nomogram. Results: The study included 129 patients (median age, 44 years; interquartile range, 37–57 years; 63 female): 90 patients for training set and 39 patients for test set. The RRS was an independent risk factor for OS with a hazard ratio of 6.01. The combined clinical and radiomics model achieved superior performance for OS prediction compared to the clinical model in both training (iAUC, 0.82 vs. 0.72, p=0.002) and test sets (0.88 vs. 0.76, p=0.04). The radiomics nomogram combined with clinical features exhibited good agreement between the actual and predicted OS with C-index of 0.83 and 0.87 in the training and test sets, respectively. Conclusion: Adding diffusion- and perfusion-weighted MRI radiomics to clinical features improved survival prediction in lowergrade glioma.
Abstract
Purpose: Lower-grade gliomas of histologic grades 2 and 3 follow heterogenous clinical outcomes, which necessitates risk stratification. This study aimed to evaluate whether diffusion-weighted and perfusion-weighted MRI radiomics allow overall survival (OS) prediction in patients with lower-grade gliomas and investigate its prognostic value. Materials and Methods: In this retrospective study, radiomic features were extracted from apparent diffusion coefficient, relative cerebral blood volume map, and Ktrans map in patients with pathologically confirmed lower-grade gliomas (January 2012–February 2019). The radiomics risk score (RRS) calculated from selected features constituted a radiomics model. Multivariable Cox regression analysis, including clinical features and RRS, was performed. The models’ integrated area under the receiver operating characteristic curves (iAUCs) were compared. The radiomics model combined with clinical features was presented as a nomogram. Results: The study included 129 patients (median age, 44 years; interquartile range, 37–57 years; 63 female): 90 patients for training set and 39 patients for test set. The RRS was an independent risk factor for OS with a hazard ratio of 6.01. The combined clinical and radiomics model achieved superior performance for OS prediction compared to the clinical model in both training (iAUC, 0.82 vs. 0.72, p=0.002) and test sets (0.88 vs. 0.76, p=0.04). The radiomics nomogram combined with clinical features exhibited good agreement between the actual and predicted OS with C-index of 0.83 and 0.87 in the training and test sets, respectively. Conclusion: Adding diffusion- and perfusion-weighted MRI radiomics to clinical features improved survival prediction in lowergrade glioma.
참고문헌 (45)
- Brat DJ, "Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas", N Engl J Med, 372, pp.2481~2498 (2015)
- Yan H, "IDH1 and IDH2 mutations in gliomas", N Engl J Med, 360, pp.765~773 (2009)
- Louis DN, "The 2021 WHO classification of tumors of the central nervous system : a summary", Neuro Oncol, 23, pp.1231~1251 (2021)
- Aibaidula A, "Adult IDH wild-type lower-grade gliomas should be further stratified", Neuro Oncol, 19, pp.1327~1337 (2017)
- Brat DJ, "cIMPACT-NOW update 3 : recommended diagnostic criteria for"diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"", Acta Neuropathol, 136, pp.805~810 (2018)
- Oberheim Bush NA, "Treatment strategies for low-grade glioma in adults", J Oncol Pract, 12, pp.1235~1241 (2016)
- Douw L, "Cognitive and radiological effects of radiotherapy in patients with low-grade glioma : long-term follow-up", Lancet Neurol, 8, pp.810~818 (2009)
- van Dijken BRJ, "Perfusion MRI in treatment evaluation of glioblastomas : clinical relevance of current and future techniques", J Magn Reson Imaging, 49, pp.11~22 (2019)
- Choi YS, "The initial area under the curve derived from dynamic contrast-enhanced MRI improves prognosis prediction in glioblastoma with unmethylated MGMT promoter", AJNR Am J Neuroradiol, 38, pp.1528~1535 (2017)
- Villanueva-Meyer JE, "MRI features and IDH mutational status of grade II diffuse gliomas : impact on diagnosis and prognosis", AJR Am J Roentgenol, 210, pp.621~628 (2018)
- Leu K, "Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas", J Neurooncol, 134, pp.177~188 (2017)
- Gillies RJ, "Radiomics : images are more than pictures, they are data", Radiology, 278, pp.563~577 (2016)
- Aerts HJ, "Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach", Nat Commun, 5, pp.4006~ (2014)
- Park CJ, "MRI features may predict molecular features of glioblastoma in isocitrate dehydrogenase wild-type lower-grade gliomas", AJNR Am J Neuroradiol, 42, pp.448~456 (2021)
- Park CJ, "Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas", Eur Radiol, 30, pp.6464~6474 (2020)
- Choi YS, "Machine learning and radiomic phenotyping of lower grade gliomas : improving survival prediction", Eur Radiol, 30, pp.3834~3842 (2020)
- Wang J, "An MRIbased radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lowergrade gliomas", Eur Radiol, 31, pp.1785~1794 (2021)
- Kim M, "Diffusionand perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase(IDH)mutation and tumor aggressiveness in diffuse lower grade glioma", Eur Radiol, 30, pp.2142~2151 (2020)
- Ren Y, "Noninvasive prediction of IDH1 mutation and ATRX expression loss in lowgrade gliomas using multiparametric MR radiomic features", J Magn Reson Imaging, 49, pp.808~817 (2019)
- Kim KJ, "Dynamic contrast-enhanced MRI and its applications in various central nervous system diseases", Investig Magn Reson Imaging, 26, pp.256~264 (2022)
- Choi HS, "Glioma grading capability : comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI", Korean J Radiol, 14, pp.487~492 (2013)
- Jung SC, "Glioma : application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading", AJNR Am J Neuroradiol, 35, pp.1103~1110 (2014)
- Ahn SH, "Association of dynamic susceptibility contrast-and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas : a retrospective study", Neuroradiol J, 36, pp.49~58 (2023)
- Morabito R, "DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife", Radiat Oncol, 14, pp.65~ (2019)
- Elshafeey N, "Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma", Nat Commun, 10, pp.3170~ (2019)
- Shiroishi MS, "Principles of T2*-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging", J Magn Reson Imaging, 41, pp.296~313 (2015)
- Fedorov A, "3D Slicer as an image computing platform for the Quantitative Imaging Network", Magn Reson Imaging, 30, pp.1323~1341 (2012)
- van Griethuysen JJM, "Computational radiomics system to decode the radiographic phenotype", Cancer Res, 77, pp.e104~e107 (2017)
- Zwanenburg A, "The image biomarker standardization initiative : standardized quantitative radiomics for high-throughput image-based phenotyping", Radiology, 295, pp.328~338 (2020)
- Friedman J, "Regularization paths for generalized linear models via coordinate descent", J Stat Softw, 33, pp.1~22 (2010)
- Heagerty PJ, "Survival model predictive accuracy and ROC curves", Biometrics, 61, pp.92~105 (2005)
- Iasonos A, "How to build and interpret a nomogram for cancer prognosis", J Clin Oncol, 26, pp.1364~1370 (2008)
- Balachandran VP, "Nomograms in oncology : more than meets the eye", Lancet Oncol, 16, pp.e173~e180 (2015)
- Contal C, "An application of changepoint methods in studying the effect of age on survival in breast cancer", Comput Stat Data Anal, 30, pp.253~270 (1999)
- Schmainda KM, "Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma : results from the ACRIN 6677", RTOG 0625 multicenter trial, 2015, pp.17, 1148~1156
- Larsson C, "Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy", Magn Reson Imaging, 68, pp.106~112 (2020)
- Bonekamp D, "Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI : comparison of intraindividually matched T1-and T2*-based bolus techniques", J Magn Reson Imaging, 42, pp.87~96 (2015)
- Lee J, "Texture feature ratios from relative CBV maps of perfusion MRI are associated with patient survival in glioblastoma", AJNR Am J Neuroradiol, 37, pp.37~43 (2016)
- Park JE, "Radiomics prognostication model in glioblastoma using diffusion-and perfusion-weighted MRI", Sci Rep, 10, pp.4250~ (2020)
- Shim KY, "Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI", Sci Rep, 11, pp.9974~ (2021)
- Pak E, "Prediction of prognosis in glioblastoma using radiomics features of dynamic contrast-enhanced MRI", Korean J Radiol, 22, pp.1514~1524 (2021)
- Gittleman H, "An independently validated survival nomogram for lower-grade glioma", Neuro Oncol, 22, pp.665~674 (2020)
- Eidel O, "Automatic analysis of cellularity in glioblastoma and correlation with ADC using trajectory analysis and automatic nuclei counting", PLoS One, 11, pp.e0160250~ (2016)
- Soni N, "Texture analysis in cerebral gliomas : a review of the literature", AJNR Am J Neuroradiol, 40, pp.928~934 (2019)
- Meyer M, "Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity", Proc Natl Acad Sci U S A, 112, pp.851~856 (2015)